MedTrace Logo

To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity

NCT02481336 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-04-14

No results posted yet for this study

Summary

To study the risk prediction of chemotherapy-induced peripheral neuropathy (CIPN) by the clinical bioinformatics and genomic profile.

Conditions

  • Neurotoxicity Syndromes

Interventions

OTHER

Questionnaires

EORTC CIPN20 and EQ-5D-3L

PROCEDURE

Peripheral nervous system examination

nerve conduction velocity (NCV), quantitative sensory test (QST), and nerve excitability test (NET)

GENETIC

Whole Genome Sequence

Genetic Test : 10 mL blood will be collected in Blood Sample Collection

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • Meng-Ru Shen, PHD · National Cheng Kung University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02481336 on ClinicalTrials.gov